Guest: Tim Walbert
Host: Bruce Japsen
The climate for innovation in the pharmaceutical and biotech industries is fraught with risk, but also holds great potential for reward. Tim Walbert, the chief executive of Horizon Therapeutics, tells host Bruce Japsen about the prospects for growth in life sciences and the biopharmaceutical industry outside of Big Pharma and what that means for physicians.
